LB Group Co., Ltd. (002601.SZ)
Jiaozuo, HA, CN
LB Group Co., Ltd. manufactures and sells titanium dioxide pigments in China and internationally. The company offers a range of chemicals, including titanium, zirconium, and lithium products. The company also offers its products under the XUELIAN and BILLIONS brand names. Its products are used in coatings, paints, plastics, papermaking, and inks. The company was formerly known as Lomon Billions Group Co., Ltd. and changed its name to LB Group Co., Ltd. in July 2021. LB Group Co., Ltd. was founded in 1955 and is headquartered in Jiaozuo, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.31% | -11.46% | -16.37% | -38.76% | -22.11% | -26.97% | -14.68% | -9.26% | -57.92% | +17.79% | -2.52% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 6 | +1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-5.5% Q1'26: +1.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-42.9% Q1'26: -72.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.8% Q1'26: -0.5% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+8.3% Q1'26: +5.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+4.3% Q1'26: +2.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.4% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.63× Q1'26: 17.17× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 1 EPS Ana. |
Dec 2027 8 Rev. Ana. 1 EPS Ana. |
Dec 2028 6 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.63B
est: 2.66B (-1.0%)
|
4.14B
est: 4.28B (-3.4%)
|
10.26B
est: 10.07B (+1.8%)
|
10.44B
est: 10.51B (-0.6%)
|
11.36B
est: 11.62B (-2.2%)
|
14.11B
est: 13.93B (+1.3%)
|
20.57B
est: 20.19B (+1.9%)
|
24.11B
est: 23.95B (+0.7%)
|
26.76B
est: 27.35B (-2.1%)
|
27.51B
est: 28.24B (-2.6%)
|
25.99B
est: 27.07B (-4.0%)
|
29.42B
27.68B – 32.64B
+8.7% YoY
|
32.45B
27.61B – 36.16B
+10.3% YoY
|
34.13B
30.53B – 37.94B
+5.2% YoY
|
| EBITDA |
337.49M
est: 743.47M (-54.6%)
|
1.02B
est: 1.20B (-15.1%)
|
3.98B
est: 2.82B (+41.4%)
|
3.60B
est: 2.94B (+22.5%)
|
4.08B
est: 3.25B (+25.7%)
|
4.43B
est: 3.89B (+13.8%)
|
7.15B
est: 5.64B (+26.7%)
|
5.79B
est: 6.69B (-13.5%)
|
6.62B
est: 7.65B (-13.4%)
|
6.83B
est: 7.29B (-6.3%)
|
5.40B
est: 6.99B (-22.7%)
|
7.60B
7.15B – 8.43B
+8.7% YoY
|
8.38B
7.13B – 9.34B
+10.3% YoY
|
8.81B
7.89B – 9.80B
+5.2% YoY
|
| EBIT |
161.37M
est: 518.53M (-68.9%)
|
598.29M
est: 834.74M (-28.3%)
|
3.11B
est: 1.96B (+58.2%)
|
2.70B
est: 2.05B (+31.9%)
|
3.13B
est: 2.27B (+38.1%)
|
3.33B
est: 2.72B (+22.5%)
|
5.68B
est: 3.94B (+44.3%)
|
4.10B
est: 4.67B (-12.1%)
|
4.14B
est: 5.33B (-22.4%)
|
3.80B
est: 4.64B (-18.1%)
|
2.15B
est: 4.45B (-51.6%)
|
4.84B
4.55B – 5.36B
+8.7% YoY
|
5.33B
4.54B – 5.94B
+10.3% YoY
|
5.61B
5.02B – 6.24B
+5.2% YoY
|
| Net Income |
111.44M
est: 358.60M (-68.9%)
|
442.11M
est: 587.83M (-24.8%)
|
2.50B
est: 3.17B (-21.0%)
|
2.29B
est: 2.78B (-17.7%)
|
2.59B
est: 3.15B (-17.6%)
|
2.29B
est: 2.78B (-17.7%)
|
4.68B
est: 4.88B (-4.2%)
|
3.42B
est: 4.15B (-17.6%)
|
3.23B
est: 3.05B (+5.6%)
|
2.17B
est: 3.04B (-28.7%)
|
1.24B
est: 2.07B (-40.0%)
|
1.74B
1.50B – 1.99B
-16.2% YoY
|
2.83B
2.45B – 3.25B
+62.9% YoY
|
3.49B
3.01B – 3.99B
+23.0% YoY
|
| SGA |
290.59M
est: 173.21M (+67.8%)
|
538.86M
est: 278.83M (+93.3%)
|
906.31M
est: 655.87M (+38.2%)
|
854.12M
est: 684.10M (+24.9%)
|
1.01B
est: 756.75M (+33.5%)
|
895.90M
est: 907.02M (-1.2%)
|
1.56B
est: 1.31B (+18.5%)
|
1.84B
est: 1.56B (+18.3%)
|
1.51B
est: 1.78B (-15.2%)
|
1.47B
est: 1.65B (-11.1%)
|
798.85M
est: 1.59B (-49.6%)
|
1.72B
1.62B – 1.91B
+8.7% YoY
|
1.90B
1.62B – 2.12B
+10.3% YoY
|
2.00B
1.79B – 2.22B
+5.2% YoY
|
| EPS |
0.16
est: 0.15 (+6.3%)
|
0.43
est: 0.25 (+74.3%)
|
1.25
est: 1.33 (-6.0%)
|
1.15
est: 1.17 (-1.3%)
|
1.29
est: 1.32 (-2.3%)
|
1.13
est: 1.17 (-3.1%)
|
2.12
est: 2.05 (+3.5%)
|
1.44
est: 1.74 (-17.3%)
|
1.38
est: 1.28 (+7.7%)
|
0.91
est: 1.27 (-28.4%)
|
0.52
est: 0.87 (-40.0%)
|
0.73
0.63 – 0.83
-16.2% YoY
|
1.18
1.02 – 1.36
+62.9% YoY
|
1.46
1.26 – 1.67
+23.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-28 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-25 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-22 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | B- | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF ASHS | 0.25% | 92.5K | 0.65% |
| 2 | Samsung KODEX China CSI300 ETF 283580.KS | 0.11% | 219.2K | 0.12% |
| 3 | HSBC MSCI China A UCITS ETF HMCT.L | 0.11% | 143.6K | 0.30% |
| 4 | Xtrackers Harvest CSI A500 UCITS ETF 1D AH50.L | 0.10% | 15.6K | 0.65% |
| 5 | iShares MSCI China A ETF CNYA | 0.08% | 180.1K | 0.60% |
| 6 | Xtrackers MSCI China A UCITS ETF 1C XX2D.L | 0.08% | 104.6K | 0.35% |
| 7 | iShares MSCI China A UCITS ETF CNYA.L | 0.08% | 2.31M | 0.40% |
| 8 | iShares MSCI China A UCITS ETF CNYE.MI | 0.08% | 76.3K | 0.45% |
| 9 | Amundi MSCI China A UCITS ETF Acc CNAA.L | 0.07% | 93.9K | 0.35% |
| 10 | KraneShares ICBCCS S&P China 500 Index UCITS ETF CHIN.L | 0.06% | 45.5K | 0.55% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jianli Chen | Vice President of R&D and Non-Independent Director | — | male |
| Liangpo Guo | CFO & Head of Accounts | — | male |
| Ming Shan Li | President Assistant & Head of Purchasing Department | — | male |
| Qing Fei Shen | Vice President of Finance & Non-Independent Director | — | male |
| Sun Liang | Vice President of Engineering & Technology | — | male |
| Wu Peng Sen | President & Director | — | male |
| Xudong Wang | Vice President of Strategy, Company Secretary & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002601.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
